DE69318909T2 - Verfahren zur Herstellung von menschlichem Wachstumshormon - Google Patents
Verfahren zur Herstellung von menschlichem WachstumshormonInfo
- Publication number
- DE69318909T2 DE69318909T2 DE69318909T DE69318909T DE69318909T2 DE 69318909 T2 DE69318909 T2 DE 69318909T2 DE 69318909 T DE69318909 T DE 69318909T DE 69318909 T DE69318909 T DE 69318909T DE 69318909 T2 DE69318909 T2 DE 69318909T2
- Authority
- DE
- Germany
- Prior art keywords
- production
- growth hormone
- human growth
- human
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title 1
- 108010000521 Human Growth Hormone Proteins 0.000 title 1
- 239000000854 Human Growth Hormone Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24093692 | 1992-09-09 | ||
JP991193 | 1993-01-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69318909D1 DE69318909D1 (de) | 1998-07-09 |
DE69318909T2 true DE69318909T2 (de) | 1998-12-24 |
Family
ID=26344726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69318909T Expired - Lifetime DE69318909T2 (de) | 1992-09-09 | 1993-09-09 | Verfahren zur Herstellung von menschlichem Wachstumshormon |
Country Status (3)
Country | Link |
---|---|
US (1) | US5496713A (de) |
EP (1) | EP0587427B1 (de) |
DE (1) | DE69318909T2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ286241A (en) * | 1995-03-29 | 1997-11-24 | Mitsui Chemicals Inc | Method of producing a peptide as a fusion protein intracellularly which is cleaved on passing the cell membrane |
NZ286884A (en) | 1995-06-29 | 1997-12-19 | Mitsui Chemicals Inc | Use of 20 kd human growth hormone in hrt, increasing serum igf-1 levels and stimulating lipolysis |
KR100236393B1 (ko) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
US5760187A (en) * | 1996-02-22 | 1998-06-02 | Mitsui Toatsu Chemicals, Inc. | Purification process of a human growth hormone |
EP0798380A3 (de) * | 1996-03-28 | 1998-04-29 | Mitsui Toatsu Chemicals, Inc. | Verfahren zur Herstellung sekretischer Proteinprodukten |
US5945296A (en) * | 1996-03-29 | 1999-08-31 | Pharmacia & Upjohn Ab | Monoclonal antibody |
US6197938B1 (en) | 1996-06-18 | 2001-03-06 | Mitsui Chemicals, Incorporated | Monoclonal antibody specific for 20K human growth hormone and a cell line producing the monoclonal antibody |
US6160089A (en) * | 1998-07-08 | 2000-12-12 | Mitsui Chemicals, Inc. | Method for secretory production of human growth hormone |
US20020150979A1 (en) * | 2000-10-04 | 2002-10-17 | Naokazu Naitou | Process for producing a protein |
US6995246B1 (en) * | 2000-10-19 | 2006-02-07 | Akzo Nobel N.V. | Methods for removing suspended particles from soluble protein solutions |
GB0319601D0 (en) * | 2003-08-20 | 2003-09-24 | Sandoz Ag | Production process |
JP2007502841A (ja) * | 2003-08-20 | 2007-02-15 | ニューレン ファーマシューティカルズ リミテッド | 成長ホルモンの20kDa胎盤性変種を用いる体形成療法 |
ATE502957T1 (de) | 2004-06-23 | 2011-04-15 | Usv Ltd | Chimeres, von den placenta- und hypophysenisoformen abgeleitetes humanes wachstumshormon und verfahren zur gewinnung der chimere |
US8282921B2 (en) * | 2004-08-02 | 2012-10-09 | Paul Glidden | tRNA synthetase fragments |
US20060024288A1 (en) * | 2004-08-02 | 2006-02-02 | Pfizer Inc. | tRNA synthetase fragments |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61151015A (ja) * | 1984-12-24 | 1986-07-09 | Mitsui Toatsu Chem Inc | 部分置換フルオロシランの製造方法 |
JPS61224988A (ja) * | 1985-03-29 | 1986-10-06 | Kunio Nakajima | ヒト20k成長ホルモン相補鎖dna増幅用大腸菌組換えプラスミド |
EP0371041A1 (de) * | 1987-06-24 | 1990-06-06 | Novo Nordisk A/S | Verfahren für die herstellung eines proteins oder polypeptides, dns-sequenz, die dieses polypeptid kodiert, mikroorganismus, der diese dns-sequenz beinhaltet, sowie das polypeptid und seine verwendung als pharmazeutisches präparat |
JPH01273591A (ja) * | 1987-08-19 | 1989-11-01 | Agency Of Ind Science & Technol | ヒト成長ホルモン分泌プラスミド、ならびにそれを用いた形質転換体および蛋白質分泌生産法 |
-
1993
- 1993-09-09 EP EP93307102A patent/EP0587427B1/de not_active Expired - Lifetime
- 1993-09-09 DE DE69318909T patent/DE69318909T2/de not_active Expired - Lifetime
- 1993-09-09 US US08/117,809 patent/US5496713A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5496713A (en) | 1996-03-05 |
DE69318909D1 (de) | 1998-07-09 |
EP0587427A1 (de) | 1994-03-16 |
EP0587427B1 (de) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69318909D1 (de) | Verfahren zur Herstellung von menschlichem Wachstumshormon | |
DE69213916D1 (de) | Verfahren zur Herstellung von L-Ambrox | |
DE69217346T2 (de) | Verfahren zur Herstellung von Mikroleuchtkörpern | |
DE69310232T2 (de) | Verfahren zur Herstellung von Organomonochlorsilan | |
DE59303220D1 (de) | Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton | |
DE69314899T2 (de) | Verfahren zur Herstellung von Polyaminoborazinen | |
DE59302489D1 (de) | Verfahren zur Herstellung von Chlor-Fluor-Butenen | |
DE69315297T2 (de) | Verfahren zur Herstellung von Omega-Alkenylchlorsilanen | |
DE69325079T2 (de) | Verfahren zur Herstellung von Triorganochlorsilane | |
DE69303057D1 (de) | Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin | |
DE69315317T2 (de) | Verfahren zur Herstellung von beta-Cyanoalkylsilanen | |
DE59305081D1 (de) | Verfahren zur herstellung von hexafluorchlorbutenen | |
DE69014042D1 (de) | Verfahren zur Herstellung von menschlichem Osteocalcin. | |
DE69318765D1 (de) | Verfahren zur Herstellung von Hydridoorganooxysilanen | |
DE69321661T2 (de) | Verfahren zur Herstellung von Triorganomonohalogensilan | |
DE69305279D1 (de) | Verfahren zur Herstellung von Dimethyltetralin | |
DE59306959D1 (de) | Verfahren zur Herstellung von Difluor- und Chlorfluorbenzodioxolen | |
DE69308193D1 (de) | Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin | |
DE59301861D1 (de) | Verfahren zur Herstellung von 2-Aryl-ethan-sulfonsäuren | |
DE69322893T2 (de) | Verfahren zur Herstellung von Epsilon-poly-L-Lysin | |
DE59304663D1 (de) | Verfahren zur Herstellung von 4-Hydroxymethyltetrahydropyran | |
DE4294717T1 (de) | Verfahren zur Herstellung von medizinischen Beuteln | |
DE59310105D1 (de) | Verfahren zur Herstellung von 2-Amino-5-methyl-pyridin | |
DE69315979T2 (de) | Verfahren zur Herstellung von 1-Phenoxy-2-aminopropan | |
DE69303656D1 (de) | Verfahren zur Herstellung von 2-Oxytetrahydrofurane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: MITSUI CHEMICALS, INC., TOKIO/TOKYO, JP |
|
8364 | No opposition during term of opposition |